Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2019 | 1 |
2023 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).
Lancet Haematol. 2019 Mar;6(3):e132-e143. doi: 10.1016/S2352-3026(18)30221-7.
Lancet Haematol. 2019.
PMID: 30824040
Free PMC article.
Clinical Trial.
A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.
Prager N, Bickett K, French N, Marcovici G.
Prager N, et al. Among authors: bickett k.
J Altern Complement Med. 2002 Apr;8(2):143-52. doi: 10.1089/acm.2002.8.143.
J Altern Complement Med. 2002.
PMID: 12006122
Clinical Trial.
Item in Clipboard
Cite
Cite